Elias Zerhouni, Jonathan Usaka | GenomeWeb
Elias Zerhouni is resigning from his position as director of the National Institutes of Health at the end of October "to pursue writing projects and explore other professional opportunities." Zerhouni said that his writing plans may touch on his experiences as head of NIH during “a time of real transition.”

Zerhouni told a group of reporters in a conference call this week that his departure is timed to synchronize with the end of the current White House administration and that he does not consider the move to be a resignation.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.